220 related articles for article (PubMed ID: 29991287)
1. Epidermal growth factor receptor based active targeting: a paradigm shift towards advance tumor therapy.
Habban Akhter M; Sateesh Madhav N; Ahmad J
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1188-1198. PubMed ID: 29991287
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor targeting in cancer: a review of trends and strategies.
Yewale C; Baradia D; Vhora I; Patil S; Misra A
Biomaterials; 2013 Nov; 34(34):8690-707. PubMed ID: 23953842
[TBL] [Abstract][Full Text] [Related]
3. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
[TBL] [Abstract][Full Text] [Related]
4. ErbB Receptors and Cancer.
Wang Z
Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
[TBL] [Abstract][Full Text] [Related]
5. Review on EGFR Inhibitors: Critical Updates.
Singh D; Attri BK; Gill RK; Bariwal J
Mini Rev Med Chem; 2016; 16(14):1134-66. PubMed ID: 26996617
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of the epidermal growth factor receptor in human cancer.
Dhomen NS; Mariadason J; Tebbutt N; Scott AM
Crit Rev Oncog; 2012; 17(1):31-50. PubMed ID: 22471663
[TBL] [Abstract][Full Text] [Related]
7. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting Epidermal Growth Factor Receptor Dimerization and Signaling Through Targeted Delivery of a Juxtamembrane Domain Peptide Mimic.
Gerhart J; Thévenin AF; Bloch E; King KE; Thévenin D
ACS Chem Biol; 2018 Sep; 13(9):2623-2632. PubMed ID: 30133245
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials.
Voldborg BR; Damstrup L; Spang-Thomsen M; Poulsen HS
Ann Oncol; 1997 Dec; 8(12):1197-206. PubMed ID: 9496384
[TBL] [Abstract][Full Text] [Related]
11. Natural tyrosine kinase inhibitors acting on the epidermal growth factor receptor: Their relevance for cancer therapy.
Liang Y; Zhang T; Zhang J
Pharmacol Res; 2020 Nov; 161():105164. PubMed ID: 32846211
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor dependence in human tumors: more than just expression?
Arteaga CL
Oncologist; 2002; 7 Suppl 4():31-9. PubMed ID: 12202786
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic insights into differential requirement of receptor dimerization for oncogenic activation of mutant EGFR and its clinical perspective.
Cho J
BMB Rep; 2020 Mar; 53(3):133-141. PubMed ID: 32172728
[TBL] [Abstract][Full Text] [Related]
14. Antitumor therapeutic strategies based on the targeting of epidermal growth factor-induced survival pathways.
Tagliaferri P; Tassone P; Blotta S; Viscomi C; Grillone F; Budillon A; Caraglia M; Venuta S
Curr Drug Targets; 2005 May; 6(3):289-300. PubMed ID: 15857289
[TBL] [Abstract][Full Text] [Related]
15. Natural Products Targeting EGFR Signaling Pathways as Potential Anticancer Drugs.
Wang X; Xu L; Lao Y; Zhang H; Xu H
Curr Protein Pept Sci; 2018 Feb; 19(4):380-388. PubMed ID: 28059040
[TBL] [Abstract][Full Text] [Related]
16. Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer.
Liu H; Lu J; Hua Y; Zhang P; Liang Z; Ruan L; Lian C; Shi H; Chen K; Tu Z
Cell Death Dis; 2015 Jan; 6(1):e1595. PubMed ID: 25590805
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor induces STAT1 expression to exacerbate the IFNr-mediated PD-L1 axis in epidermal growth factor receptor-positive cancers.
Cheng CC; Lin HC; Tsai KJ; Chiang YW; Lim KH; Chen CG; Su YW; Peng CL; Ho AS; Huang L; Chang YC; Lin HC; Chang J; Chang YF
Mol Carcinog; 2018 Nov; 57(11):1588-1598. PubMed ID: 30035369
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer.
Bhola NE; Grandis JR
Front Biosci; 2008 Jan; 13():1857-65. PubMed ID: 17981673
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between EGFR and IL-6 drives oncogenic signaling and offers therapeutic opportunities in cancer.
Ray K; Ujvari B; Ramana V; Donald J
Cytokine Growth Factor Rev; 2018 Jun; 41():18-27. PubMed ID: 29680500
[TBL] [Abstract][Full Text] [Related]
20. Grb7, a Critical Mediator of EGFR/ErbB Signaling, in Cancer Development and as a Potential Therapeutic Target.
Chu PY; Tai YL; Shen TL
Cells; 2019 May; 8(5):. PubMed ID: 31083325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
